Skip to content

Drug interactions

Etoposide + Fosaprepitant

Severity: Minor

Etoposide and Fosaprepitant: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosaprepitant, converted to aprepitant, is a moderate CYP3A4 inhibitor after single-dose use, with a modest effect on etoposide exposure. Clinically significant toxicity is uncommon, since the combination is routinely used in chemotherapy regimens.

What this interaction means in plain words

Etoposide and Fosaprepitant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Etoposide belongs to Oncology; Fosaprepitant belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Weak to moderate transient CYP3A4 inhibition slightly reduces etoposide clearance.

What to do

No routine adjustment is needed; monitor blood counts as usual during etoposide therapy.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Etoposide and Fosaprepitant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Etoposide with Fosaprepitant?

MediHelp rates the interaction as minor. Etoposide and Fosaprepitant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fosaprepitant, converted to aprepitant, is a moderate CYP3A4 inhibitor after single-dose use, with a modest effect on etoposide exposure. Clinically significant toxicity is uncommon, since the combination is routinely used in chemotherapy regimens.

How serious is the interaction between Etoposide and Fosaprepitant?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine adjustment is needed; monitor blood counts as usual during etoposide therapy.

What other medicines interact with Etoposide?

MediHelp also lists interactions of Etoposide with, for example, Adenovirus types 4 and 7 live, Pentostatin, Cyclosporin. The full list is on the Etoposide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in